Assessing the Implementation of Digital Innovations in Response to the COVID-19 Pandemic to Address Key Public Health Functions: Scoping Review of Academic and Nonacademic Literature.

Background: Digital technologies have been central to efforts to respond to the COVID-19 pandemic. In this context, a range of literature has reported on developments regarding the implementation of new digital technologies for COVID-19-related surveillance, prevention, and control.

Objective: In this study, scoping reviews of academic and nonacademic literature were undertaken to obtain an overview of the evidence regarding digital innovations implemented to address key public health functions in the context of the COVID-19 pandemic.

How do NIHR peer review panels use bibliometric information to support their decisions?

Bibliometrics is widely used as an evaluation tool to assist prospective R&D decision-making. In the UK, for example, the National Institute for Health Research (NIHR) has employed bibliometric analysis alongside wider information in several awarding panels for major funding schemes. In this paper, we examine various aspects of the use of bibliometric information by members of these award selection panels, based on interviews with ten panel members from three NIHR panels, alongside analysis of the information provided to those panels.

Analysis of Research and Education Indicators to Support Designation of Academic Health Science Centres in England.

In April 2013, the Department of Health (DH) announced an open competition to designate Academic Health Science Centres (AHSCs) in England. To support the current competition, the DH commissioned RAND Europe to compile and analyse various types of publicly available data and quality assessments in the domains of medical research and health education. This article presents the results of this analysis in the form of summary "tables of excellence," focusing on medical schools/academic partners likely to seek AHSC status.

Regulatory Cultures and Research Governance.

This research is intended to help improve understanding of health research governance in the UK by exploring the regulatory practices and cultures in other countries and sectors. It is a comparative study of the practice of those who are subject to regulatory requirements in the health research, medical drugs, environmental and financial sectors. The research is informed by a review of a small subset of literature which is particularly relevant to this question, and focuses on different elements of regulation and regulatory governance for each of the different sectors.